Life-threatening Vasospastic Angina Induced by Carteolol Eye Drops

被引:0
作者
Eto, Ryo [1 ]
Kawano, Hiroaki
Suzuki, Ayaka
Akashi, Ryohei
Ikeda, Satoshi
Maemura, Koji
机构
[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cardiovasc Med, Nagasaki, Japan
关键词
vasospastic angina; ophthalmic beta-blocker; carteolol; SPASM; ASTHMA;
D O I
10.2169/internalmedicine.0495-22
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vasospastic angina (VSA) can be worsened by oral nonselective beta-blockers. Ophthalmic carteolol eye drops are nonselective beta-blockers and effective against glaucoma and ocular hypertension. Systemic effects of ophthalmic beta-blockers on VSA have not yet been reported. We herein report a case of VSA that developed after a patient started carteolol eye drops for ocular hypertension. Even though benidipine, a calcium channel blocker, was started, a VSA attack with incessant non-sustained ventricular tachycardia occurred. Once the carteolol eyedrops were discontinued, the VSA resolved. This case demonstrates that carteolol eye drops can induce life-threatening VSA.
引用
收藏
页码:2513 / 2516
页数:4
相关论文
共 18 条
[1]   CORONARY-ARTERY SPASM INDUCED BY PHENYLEPHRINE EYEDROPS [J].
ALDER, AG ;
MCELWAIN, GE ;
MARTIN, JH ;
JEGLUM, EL .
ARCHIVES OF INTERNAL MEDICINE, 1981, 141 (10) :1384-1385
[2]   Bradycardia Shock Caused by the Combined Use of Carteolol Eye Drops and Verapamil in an Elderly Patient with Atrial Fibrillation and Chronic Kidney Disease [J].
Arai, Riku ;
Fukamachi, Daisuke ;
Monden, Masaki ;
Akutsu, Naotaka ;
Murata, Nobuhiro ;
Okumura, Yasuo .
INTERNAL MEDICINE, 2021, 60 (01) :79-83
[3]   Asthma mortality in Australia in the 21st century: a case series analysis [J].
Goeman, Dianne P. ;
Abramson, Michael J. ;
McCarthy, Edwina A. ;
Zubrinich, Celia M. ;
Douglass, Jo A. .
BMJ OPEN, 2013, 3 (05)
[4]   Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers [J].
Ito, A ;
Fukumoto, Y ;
Shimokawa, H .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 44 (04) :480-485
[5]   Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops [J].
Korte, JM ;
Kaila, T ;
Saari, KM .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2002, 240 (06) :430-435
[6]   Respiratory effect of beta-blocker eye drops in asthma: population-based study and meta-analysis of clinical trials [J].
Morales, Daniel R. ;
Dreischulte, Tobias ;
Lipworth, Brian J. ;
Donnan, Peter T. ;
Jackson, Cathy ;
Guthrie, Bruce .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (03) :814-822
[7]   RETRACTED: Prescribing of β-adrenoceptor antagonists in asthma: an observational study (Retracted Article) [J].
Morales, Daniel R. ;
Guthrie, Bruce ;
Lipworth, Brian J. ;
Donnan, Peter T. ;
Jackson, Cathy .
THORAX, 2011, 66 (06) :502-507
[8]   CLINICAL CHARACTERISTICS ASSOCIATED WITH MYOCARDIAL-INFARCTION, ARRHYTHMIAS, AND SUDDEN-DEATH IN PATIENTS WITH VASOSPASTIC ANGINA [J].
NAKAMURA, M ;
TAKESHITA, A ;
NOSE, Y .
CIRCULATION, 1987, 75 (06) :1110-1116
[9]   Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma [J].
Netland, PA ;
Weiss, HS ;
Stewart, WC ;
Cohen, JS ;
Nussbaum, LL ;
Abrams, D ;
Schwartz, G ;
Hughes, P ;
Adelson, A ;
Brink, M ;
Myers, M ;
Bahr, R ;
Dowling, JL ;
Richards, F ;
Geltzer, A ;
Hofmann, RJ ;
SnadyMcCoy, L ;
Bartnik, LA ;
Beneke, J ;
Barr, L ;
Muroski, D ;
Neal, J ;
Clevenger, C ;
Summitt, B ;
Lee, A ;
Cohen, J ;
Riccio, KA ;
Luechauer, A ;
DuBiner, H ;
Cribbs, S ;
Laibovitz, R ;
Neck, K ;
Mundorf, T ;
Otero, D ;
Netland, PA ;
Vivolo, DA ;
Schwartz, L ;
Carmichael, P ;
Conner, R ;
Nowinski, T ;
Kesselring, J ;
Bollenbach, A ;
Foley, A ;
Stewart, W ;
Stewart, J ;
Weiss, H ;
Schwartz, A ;
Latham, BD .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 123 (04) :465-477
[10]  
ODEH M, 1991, J FAM PRACTICE, V32, P97